| Record ID | marc_columbia/Columbia-extract-20221130-016.mrc:63214747:2816 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-016.mrc:63214747:2816?format=raw |
LEADER: 02816cam a22005414a 4500
001 7706075
005 20221201022207.0
008 081201s2009 enkaf b 001 0 eng
010 $a 2008052079
015 $aGBA8E1211$2bnb
016 7 $a101490370$2DNLM
016 7 $a014857650$2Uk
019 $a288985559
020 $a9780470092545 (HB)
020 $a0470092548 (HB)
020 $a9780470092552 (PB)
020 $a0470092556 (PB)
029 1 $aNLM$b101490370
029 1 $aCDX$b4949058
029 1 $aCDX$b4949059
029 1 $aIG#$b9780470092545
029 1 $aNZ1$b12889917
029 1 $aNLGGC$b319646033
029 1 $aZWZ$b13777527X
035 $a(OCoLC)ocn216941051
035 $a(OCoLC)216941051$z(OCoLC)288985559
035 $a(NNC)7706075
035 $a7706075
040 $aDNLM/DLC$cDLC$dNLM$dBTCTA$dYDXCP$dBAKER$dBWKUK$dCDX$dUKM$dIG#$dZWZ
042 $apcc
050 00 $aRC271.C5$bA35 2009
060 00 $a2009 E-866
060 10 $aQZ 267$bA298c 2009
082 00 $a616.99/4061$222
100 1 $aAirley, Rachel.$0http://id.loc.gov/authorities/names/n2008185051
245 10 $aCancer chemotherapy /$cRachel Airley.
260 $aChichester, UK ;$aHoboken, NJ :$bWiley-Blackwell,$c2009.
300 $ax, 341 pages, 8 unnumbered pages of plates :$billustrations (some color) ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references (p. [299]-330) and index.
505 0 $aCancer epidemiology -- Histopathology of cancer -- Carcinogenesis, malignant transformation, and progression -- Molecular biology of cancer : oncogenes and tumour suppressor genes -- Tumour metastasis : a convergence of many theories -- Health professionals in the treatment of cancer -- Principles of cancer chemotherapy -- Classic anticancer agents -- The philosophy of cancer research -- Novel anticancer agents -- Clinical trials -- Tumour hypoxia -- Antiangiogenic and antivascular agents -- Tyrosine kinase inhibitors -- Ras inhibitors -- Inhibitors of the Akt/PKB pathway -- Targeting stress proteins: HSP90 inhibitors -- The proteasome -- Checkpoint protein kinases as novel targets : mammalian target of rapamycin (mTOR) -- Telomerase -- Histone deacetylase : an epigenetic drug target -- Pharmaceutical problems in cancer chemotherapy -- Oncology pharmacy at home and abroad -- Practice exam questions.
650 0 $aCancer$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh85019497
650 12 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
650 22 $aAntineoplastic Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000970Q000627
650 7 $aCancer$xChimiothérapie.$2ram
650 7 $aTumeurs$xtraitement médicamenteux.$2fmesh
852 00 $boff,hsl$hRC271.C5$iA35 2009